Cassava Sciences Inc (SAVA)
21.22
-0.05
(-0.24%)
USD |
NASDAQ |
Apr 18, 16:00
21.22
0.00 (0.00%)
After-Hours: 20:00
Cassava Sciences Market Cap: 917.24M for April 18, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 17, 2024 | 919.40M |
| April 16, 2024 | 909.03M |
| April 15, 2024 | 864.94M |
| April 12, 2024 | 983.37M |
| April 11, 2024 | 1.129B |
| April 10, 2024 | 1.059B |
| April 09, 2024 | 1.098B |
| April 08, 2024 | 1.019B |
| April 05, 2024 | 921.13M |
| April 04, 2024 | 885.25M |
| April 03, 2024 | 889.57M |
| April 02, 2024 | 851.97M |
| April 01, 2024 | 877.04M |
| March 28, 2024 | 877.04M |
| March 27, 2024 | 882.66M |
| March 26, 2024 | 851.97M |
| March 25, 2024 | 851.54M |
| March 22, 2024 | 856.29M |
| March 21, 2024 | 915.51M |
| March 20, 2024 | 949.66M |
| March 19, 2024 | 950.52M |
| March 18, 2024 | 919.83M |
| March 15, 2024 | 920.26M |
| March 14, 2024 | 894.33M |
| March 13, 2024 | 892.60M |
| Date | Value |
|---|---|
| March 12, 2024 | 899.52M |
| March 11, 2024 | 797.07M |
| March 08, 2024 | 811.77M |
| March 07, 2024 | 832.09M |
| March 06, 2024 | 857.59M |
| March 05, 2024 | 925.45M |
| March 04, 2024 | 973.00M |
| March 01, 2024 | 994.18M |
| February 29, 2024 | 993.32M |
| February 28, 2024 | 991.15M |
| February 27, 2024 | 994.18M |
| February 26, 2024 | 947.50M |
| February 23, 2024 | 926.26M |
| February 22, 2024 | 950.75M |
| February 21, 2024 | 935.55M |
| February 20, 2024 | 949.06M |
| February 16, 2024 | 1.003B |
| February 15, 2024 | 1.038B |
| February 14, 2024 | 1.018B |
| February 13, 2024 | 1.006B |
| February 12, 2024 | 1.052B |
| February 09, 2024 | 1.058B |
| February 08, 2024 | 1.066B |
| February 07, 2024 | 1.073B |
| February 06, 2024 | 999.33M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
17.56M
Minimum
May 20 2019
5.414B
Maximum
Jul 28 2021
1.005B
Average
936.29M
Median
Market Cap Benchmarks
| Amylyx Pharmaceuticals Inc | 133.53M |
| MannKind Corp | 1.106B |
| Clearside Biomedical Inc | 99.38M |
| Lantern Pharma Inc | 63.05M |
| NovaBay Pharmaceuticals Inc | 2.471M |
Market Cap Related Metrics
| PS Ratio | 21.64 |
| Price to Book Value | 6.672 |
| Price | 21.22 |
| Earnings Yield | -10.93% |
| Operating PE Ratio | 28.37 |
| Normalized PE Ratio | 4.458 |